RESUMO
A series of new hydroxybenzoic and hydroxycinnamic acid flavon-3-yl esters were synthesized in order to obtain compounds targeting the human immunodeficiency virus (HIV) type 1 integrase (IN). The esters were tested for anti-IN and anti-reverse transcriptase (RT) activity in enzyme assays and for anti-HIV-1, anti-proliferative and anti-topoisomerase activity in cell-based assays. In enzyme assays, the two gallic acid flavon-3-yl esters showed a notable IN inhibition (IC50 values were 8.3 and 9.1 microM, respectively), while the two caffeic acid flavon-3-yl esters exhibited a modest activity (IC50 75 and 60 microM, respectively). Replacement of hydroxyl groups resulted in loss of potency. Caffeic acid 3',4'-dichloroflavon-3-yl ester also inhibited the RT activity whereas it was not active on human topoisomerases. It therefore represents an interesting example of a compound specifically targeting more than one step of the virus replication cycle.
Assuntos
Fármacos Anti-HIV/síntese química , Ácidos Cumáricos/síntese química , Flavonoides/síntese química , Inibidores de Integrase de HIV/síntese química , Integrase de HIV/efeitos dos fármacos , HIV-1/efeitos dos fármacos , Hidroxibenzoatos/síntese química , Fármacos Anti-HIV/química , Fármacos Anti-HIV/farmacologia , Linhagem Celular , Ácidos Cumáricos/química , Ácidos Cumáricos/farmacologia , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/farmacologia , Esterificação , Flavonoides/química , Flavonoides/farmacologia , Inibidores de Integrase de HIV/química , Inibidores de Integrase de HIV/farmacologia , Transcriptase Reversa do HIV/antagonistas & inibidores , HIV-1/enzimologia , Humanos , Hidroxibenzoatos/química , Hidroxibenzoatos/farmacologia , Estrutura Molecular , Inibidores da Transcriptase Reversa/farmacologia , Relação Estrutura-Atividade , Inibidores da Topoisomerase IIRESUMO
Two oligodeoxynucleotide (oligodN) binding proteins of 100-110 kDa on plasma membranes of human cell lines were recently identified by us. These two proteins seemed to play a role in oligodN uptake. In this study, the impact of the chain length and the sequence of the oligodN on the interaction with those two proteins was investigated. Chain length of oligodN was an important determinant, but not the sole determinant for the interaction. Binding affinity of oligodNs was determined predominantly by base composition, where pyrimidine bases but not purine bases were required in the sequence to retain high affinity. The binding kinetics of the homopolymers of deoxycytidine (dC21) and deoxythymidine (dT21) suggests that the proteins may have different binding sites, with one site preferring thymine bases and the other cytosine bases. Moreover, some additional plasma membrane proteins were identified, with an apparent molecular mass ranging from 40 to 58 kDa, which could bind thymine bases but not cytosine bases.
Assuntos
Proteínas de Membrana/metabolismo , Oligodesoxirribonucleotídeos/metabolismo , Composição de Bases , Ligação Competitiva , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Humanos , Cinética , Proteínas de Membrana/química , Peso Molecular , Oligodesoxirribonucleotídeos/química , Ligação Proteica , Desnaturação Proteica , Células Tumorais CultivadasRESUMO
A series of derivatives belonging to a new class of compounds (R4-todit) were highly cytotoxic to a panel of leukaemia- and solid tumour-derived cell lines (IC50 = 0.06-20 microM). The most potent compound was the butyl4 derivative (IC50 = 0.06-5.1 microM); T leukaemia and melanoma cells were the most susceptible cells to this inhibitor (IC50 0.06 microM and 0.1 microM, respectively). The effect of butyl4-todit was irreversible, and led to progressive cell death. The compound showed a comparable potency against exponentially growing and stationary phase cells, and against cell lines expressing the MDR phenotype. The cytotoxicity of butyl4-todit in human normal PBL was up to 20 fold lower than that shown against T leukaemia cells. When tested for antiangiogenic activity in vivo, 1.5 mg/Kg butyl4-todit resulted in over 70% inhibition of the angiogenesis process induced in mice by Kaposi's sarcoma cell secreted products.
Assuntos
Antineoplásicos/toxicidade , Compostos Heterocíclicos com 3 Anéis/toxicidade , Imidazóis/toxicidade , Tionas/toxicidade , Animais , Antineoplásicos/química , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Meios de Cultura , Doxorrubicina/toxicidade , Resistência a Múltiplos Medicamentos , Células HeLa , Compostos Heterocíclicos com 3 Anéis/química , Humanos , Imidazóis/química , Células KB , Leucemia de Células T , Linfócitos/efeitos dos fármacos , Linfócitos/patologia , Masculino , Melanoma , Camundongos , Camundongos Endogâmicos , Neovascularização Patológica/prevenção & controle , Sarcoma de Kaposi/irrigação sanguínea , Relação Estrutura-Atividade , Tionas/química , Células Tumorais CultivadasRESUMO
Among a series of unmodified phosphodiester (PO)-oligodeoxynucleotides (PO-ODNs) complementary to some of the human immunodeficiency virus type 1 (HIV-1) regulatory genes, several PO-ODN sequences complementary to the vpr gene (PO-ODNs-a-vpr, where a-vpr is the antisense vpr sequence) emerged as potent inhibitors (at concentrations of 0.8 to 3.3 microM) of HIV-1 multiplication in de novo infected MT-4 cells, while they showed no cytotoxicity for uninfected cells at concentrations up to 100 microM. Unlike phosphorothioate counterparts, PO-ODN-a-vpr sequences were not inhibitory to HIV-2 multiplication in de novo infected C8166 cells and neither prevented the fusion between chronically infected and bystander CD4+ cells nor inhibited the activity of the HIV-1 reverse transcriptase in enzyme assays. Moreover, they were not inhibitory to HIV-1 multiplication in chronically infected cells. Delayed addition experiments showed that PO-ODNs-a-vpr inhibit an event in the HIV-1 replication cycle following adsorption to the host cell, but preceding reverse transcription. Structure-activity relationship studies indicated that the antiviral activity of the test PO-ODN-a-vpr sequences is not related to an antisense mechanism but to the presence, within the active sequences, of contiguous guanine residues. Physical characterization of the test PO-ODNs suggested that the active structure is a tetramer stabilized by G quartets (i.e., four G residues connected by eight hydrogen bonds).
Assuntos
Fármacos Anti-HIV/farmacologia , HIV-1/efeitos dos fármacos , Oligonucleotídeos/farmacologia , Fármacos Anti-HIV/análise , Fusão Celular , Células Cultivadas , Dicroísmo Circular , Genes Virais , Infecções por HIV/virologia , Transcriptase Reversa do HIV/antagonistas & inibidores , HIV-2/efeitos dos fármacos , Humanos , Oligonucleotídeos/análise , Relação Estrutura-Atividade , Replicação Viral/efeitos dos fármacosRESUMO
With the aim of developing novel inhibitors of human immunodeficiency virus, various derivatives (10-17) related to 5H-pyrrolo[1,2-b] [1,2,5]benzothiadiazepine (PBTD) were prepared and tested in vitro. The title tricyclic derivatives were obtained by intramolecular cyclization of the open-chain intermediate arylpyrrylsulfones, followed by N-alkylation at position 10. Among test derivatives some 10-alkyl-5H-pyrrolo[1,2-b] [1,2,5]benzothiadiazepin-11(10H)-one-5,5-dioxides were found to exert potent and specific activity against HIV-1. In particular, 7-chloro derivatives 11i and j showed a potency comparable to that of nevirapine. However, when the chloro atom was shifted to the 8 position, the related products were scarcely active or totally inactive. Replacement of the pyrrole with pyrrolidine led to inactive products and the reduction of SO2 to S strongly diminished the antiviral potency. PBTD derivatives active in cell cultures were also inhibitory to the recombinant HIV-1 RT in enzyme assays, thus allowing the conclusion that PBTDs are a new class of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Assuntos
Fármacos Anti-HIV/farmacologia , Transcriptase Reversa do HIV/efeitos dos fármacos , HIV-1/enzimologia , Inibidores da Transcriptase Reversa/farmacologia , Tiazepinas/farmacologia , Fármacos Anti-HIV/química , Linhagem Celular , HIV-1/efeitos dos fármacos , Humanos , Espectroscopia de Ressonância Magnética , Inibidores da Transcriptase Reversa/química , Espectrofotometria Infravermelho , Relação Estrutura-Atividade , Tiazepinas/química , Replicação Viral/efeitos dos fármacosRESUMO
The synthesis and the in vitro anti-HIV-1 activity of novel pyrrolo annulated benzothiadiazepine acetic acids and some related derivatives are reported. The new compounds share chemical features with pyrrolo[1,2-d][1,4]benzodiazepin-6-one 1 and Ro 5-3335 pyrrylbenzodiazepinone 4, two inhibitors of HIV-replication at the level of reverse transcriptase (RT) and transcriptional transactivation by Tat, respectively. Two derivatives, namely methyl 10,11-dihydropyrrolo[1,2-b][1,2,5]benzothiadiazepine-11-acetic-5,5 -dioxide (5a) and 1,12b-dihydro-2H-azeto[2,1-d]pyrrolo[1,2-b][1,2,5]benzoth iadiazepin-2-one 8,8-dioxide (7a), were found to exhibit a significant, although not very potent, activity against human immunodeficiency virus Type 1 (HIV-1).
Assuntos
Antivirais/síntese química , HIV/efeitos dos fármacos , Pirróis/síntese química , Tiazepinas/síntese química , Antivirais/farmacologia , Linhagem Celular , Efeito Citopatogênico Viral/efeitos dos fármacos , Genes tat/efeitos dos fármacos , HIV/enzimologia , HIV-1/efeitos dos fármacos , HIV-1/enzimologia , HIV-2/efeitos dos fármacos , HIV-2/enzimologia , Humanos , Pirróis/farmacologia , Inibidores da Transcriptase Reversa/síntese química , Inibidores da Transcriptase Reversa/farmacologia , Relação Estrutura-Atividade , Tiazepinas/farmacologia , Transcrição Gênica/efeitos dos fármacosRESUMO
Previous studies showed that some 2'-alkyloxyisoxazoles 2b-d obtained from 3-(diethylamino)-5-(2'hydroxy-4'-methoxyphenyl)isoxazole 2a were endowed with an interesting anti-group B rhinovirus activity (action on HRV-2 serotype). Other isoxazoles (WIN compounds) are well known to have anti-group A rhinovirus activity (action on HRV-14 serotype). To obtain an action similar to that of WIN compounds, starting from 2a, the 2'-acyl (3,4,5) and 2'alkyl (6,8) derivatives were synthesized. Also some Mannich bases (9,10) and bisisoxazoles (7,11,13,14) were studied. Though some of the tested compounds mainly exhibited anti-group B rhinovirus activity, their potency was less intense with respect to the above mentioned compounds 2b-d. The only N-methylpiperazinomethyl derivative 10 was slightly active against both tested serotypes.
Assuntos
Antivirais/síntese química , Isoxazóis/síntese química , Rhinovirus/efeitos dos fármacos , Antivirais/farmacologia , Efeito Citopatogênico Viral/efeitos dos fármacos , HIV-1/efeitos dos fármacos , Células HeLa , Humanos , Isoxazóis/farmacologia , Replicação Viral/efeitos dos fármacosRESUMO
Two oligodeoxyribonucleotide (oligodN) binding proteins of approximately 100-110 kDa were identified in the plasma membranes of human HL-60, HepG2, H1, and KB cells by a photolabeling technique. Solubilization of cellular membranes with a nonionic detergent did not interfere with the binding of these two proteins to oligodNs, and both proteins were susceptible to serine protease action. The binding affinities of these two proteins to oligodNs were found to be similar; Scatchard plot analysis revealed the Kd for phosphodiester (PO) 21-mer oligodeoxycytidine to be 60 nM and binding sites numbered approximately 1.2 x 10(6)/cell for HepG2 cells. Both phosphorothioate (PS) and PO oligodNs could bind to these two proteins with the binding affinity for PS oligodNs being much stronger than that for PO oligodNs. The binding to oligodNs was affected by the ionic strength of the reaction. Dextran sulfate, tRNA, and double-stranded DNA inhibited the binding of oligodNs, whereas ATP, ADP, AMP, and TTP had no effect. Given their high affinity for oligodNs, these membranes proteins may play an important role in the action of oligodNs.
Assuntos
Proteínas de Transporte/metabolismo , Membrana Celular/metabolismo , Oligodesoxirribonucleotídeos/metabolismo , Sequência de Bases , Transporte Biológico , Cálcio/farmacologia , Carcinoma Hepatocelular , Proteínas de Transporte/química , Proteínas de Transporte/isolamento & purificação , Linhagem Celular , Eletroforese em Gel de Poliacrilamida , Células HL-60 , Humanos , Células KB , Cinética , Neoplasias Hepáticas , Linfoma de Células B , Magnésio/farmacologia , Dados de Sequência Molecular , Peso Molecular , Serina Endopeptidases , Sódio/farmacologia , Especificidade por Substrato , TionucleotídeosRESUMO
The synthesis and the evaluation of cytotoxicity and anti-HIV-1 activity of new aryl pyrrolyl (8) and aryl indolyl (9) sulfones are reported. Preparation of above sulfones was achieved by reacting arylsulfonyl chlorides with substituted pyrroles and indoles or by condensing sulfonamides with 2,5-dimethoxytetrahydrofuran in glacial acetic acid according to the Clauson-Kaas method. Chemical requisites relevant to the anti-HIV-1 activity of these compounds are both a 2-sulfonyl-4-chloroanilino moiety and an alkoxycarbonyl group at position 2 of the pyrrole ring. The best activity and selectivity were obtained with ethoxycarbonyl and isopropoxycarbonyl substituents. Substitutions at the amino group of the pharmacophore moiety led to inactive products (alkylation) or weakened (acylation) anti-HIV-1 activity. Among test derivatives, 16 compounds showed EC50 values ranging between 10 and 1 microM, and five (8b',d',f',h'j') showed EC50S in the sub-micromolar range. The compounds were active against HIV-1, both wild type and AZT-resistant strains, but not against HIV-2. Moreover, in enzyme assays they potently inhibited the HIV-1 recombinant reverse transcriptase, were 10 times less active against enzymes from nevirapine- and TIBO-resistant strains, and were totally inactive against the HIV-2 recombinant enzyme. Interestingly, some compounds (8r'-y') were inactive against the recombinant reverse transcriptase while being active in tissue culture.
Assuntos
Antivirais/farmacologia , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Ácidos Sulfínicos/química , Sulfonas/farmacologia , Antivirais/química , Linhagem Celular , Efeito Citopatogênico Viral/efeitos dos fármacos , HIV-1/patogenicidade , HIV-2/patogenicidade , Espectroscopia de Ressonância Magnética , Sulfonas/químicaRESUMO
As an approach to more extensive structural modifications of [(oxazolylphenoxy)alkyl]isoxazoles, we synthesized new compounds characterized by the replacement of the isoxazole nucleus with furan, pyrrole, and thiophene rings and by the presence of a ketocarbonyl group in the aliphatic chain connecting these pentatomic heterocycles to the 4-(4,5-dihydro-2-oxazolyl)phenoxy, 4-(ethoxycarbonyl)phenoxy, and 4-carboxyphenoxy moieties. Some pentamethylene derivatives were also prepared, and their antirhinovirus activity was compared to that of the corresponding ketomethylene derivatives. Syntheses were carried out by Friedel-Crafts acylation of the above pentatomic heterocycles and subsequent reaction of chloroalkyl ketones with the proper 4-substituted phenol. Reduction of the ketone function afforded the related polymethylene derivatives. The new compounds were tested for antirhinovirus activity and cytotoxicity in comparison with WIN 51711, used as reference drug. Inspection of the structure-activity relationships revealed that the thiophene ring and the carbonyl group are the structural components which to a large extent contribute to the positive biological profile in terms of both wideness of spectrum and low cytotoxicity. Among the various derivatives, compounds 8e,d showed in vitro the same potency of WIN 51711 but a cytotoxicity at least 10 times lower.
Assuntos
Antivirais/síntese química , Antivirais/farmacologia , Oxazóis/síntese química , Oxazóis/farmacologia , Rhinovirus/efeitos dos fármacos , Efeito Citopatogênico Viral/efeitos dos fármacos , Células HeLa , Humanos , Relação Estrutura-Atividade , Sais de Tetrazólio , TiazóisRESUMO
-2',3'-Seco nucleosides 5 carrying fluorine and sulfur substituents at C-3' and C-5', respectively, of acyclic sugar moiety were synthesized in enantiomerically and diastereoisomerically pure form. These products and some structurally similar 1',2'-seco-2'-nor-and 1',2'-seco-nucleosides 3 and 4 were tested in vitro for cytotoxicity and antiviral activity. At non-cytotoxic concentrations the compounds were inactive against human immunodeficiency virus and herpes simplex virus type-1.